Literature DB >> 27566388

Possible effect of abatacept on the progression of interstitial lung disease in rheumatoid arthritis patients.

Tamao Nakashita1, Katsutoshi Ando2, Kazuhisa Takahashi3, Shinji Motojima4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27566388     DOI： 10.1016/j.resinv.2016.03.001

Source DB:  PubMed          Journal:  Respir Investig        ISSN： 2212-5345


× No keyword cloud information.
  5 in total

1.  Immunologist's Perspectives on Assessment and Management of Lung Disease in CVID: a Survey of the Membership of the Clinical Immunology Society and the European Society for Immunodeficiencies.

Authors:  Javeed Akhter; Cheryl A Lefaiver; Christopher Scalchunes; Michael DiGirolamo; Klaus Warnatz
Journal:  J Clin Immunol       Date:  2018-04-08       Impact factor: 8.317

2.  Safety and Effectiveness of Abatacept in a Prospective Cohort of Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease.

Authors:  Natalia Mena-Vázquez; Marta Rojas-Gimenez; Clara Fuego-Varela; Aimara García-Studer; Nair Perez-Gómez; Carmen María Romero-Barco; Francisco Javier Godoy-Navarrete; Sara Manrique-Arija; Myriam Gandía-Martínez; Jerusalem Calvo-Gutiérrez; Pilar Morales-Garrido; Coral Mouriño-Rodriguez; Patricia Castro-Pérez; Isabel Añón-Oñate; Francisco Espildora; María Carmen Aguilar-Hurtado; Ana Hidalgo Conde; Rocío Arnedo Díez de Los Ríos; Eva Cabrera César; Rocío Redondo-Rodriguez; María Luisa Velloso-Feijoo; Antonio Fernández-Nebro
Journal:  Biomedicines       Date:  2022-06-22

Review 3.  Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows.

Authors:  Giulia Cassone; Andreina Manfredi; Caterina Vacchi; Fabrizio Luppi; Francesca Coppi; Carlo Salvarani; Marco Sebastiani
Journal:  J Clin Med       Date:  2020-04-10       Impact factor: 4.241

4.  Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study.

Authors:  Giulia Cassone; Andreina Manfredi; Fabiola Atzeni; Vincenzo Venerito; Caterina Vacchi; Valentina Picerno; Federica Furini; Gian Luca Erre; Paola Tomietto; Anna Laura Fedele; Giovanni Della Casa; Valeria Nucera; Chiara Giannitti; Carlo Salvarani; Marco Sebastiani
Journal:  J Clin Med       Date:  2020-01-19       Impact factor: 4.241

5.  Abatacept in rheumatoid arthritis-associated interstitial lung disease: short-term outcomes and predictors of progression.

Authors:  Marika Tardella; Marco Di Carlo; Marina Carotti; Andrea Giovagnoni; Fausto Salaffi
Journal:  Clin Rheumatol       Date:  2021-07-27       Impact factor: 2.980
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.